A detailed history of Hrt Financial LP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 14,701 shares of VINC stock, worth $2,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,701
Holding current value
$2,205
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.51 - $0.84 $7,497 - $12,348
14,701 New
14,701 $10,000
Q1 2021

May 17, 2021

SELL
$22.6 - $31.0 $714,363 - $979,879
-31,609 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$12.85 - $19.95 $406,175 - $630,599
31,609 New
31,609 $660,000

Others Institutions Holding VINC

About Vincerx Pharma, Inc.


  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $3.18M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.